Adia Nutrition, Inc. (ADIA)

Market Cap	11.42M +1,069.8%
Revenue (ttm)	6.38K -98.1%
Net Income	-181.07K
EPS	-0.00
Shares Out	94.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131,700
Average Volume	64,887
Open	0.1130
Previous Close	0.0650
Day's Range	0.1000 - 0.1700
52-Week Range	0.0177 - 0.2777
Beta	-10.57
RSI	41.23
Earnings Date	Apr 20, 2026

About Adia Nutrition

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. It operates in three segments: Biolete, Adia Med, and Adia Labs. The company provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. It also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1999
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ADIA